Penumbra
PEN
#1722
Rank
S$16.10 B
Marketcap
S$409.43
Share price
-0.24%
Change (1 day)
25.17%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$0.54 Billion

According to Penumbra's latest financial reports the company's total liabilities are S$0.54 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$0.51 B-1.43%
2024-12-31S$0.51 B4.25%
2023-12-31S$0.49 B-0.07%
2022-12-31S$0.49 B27.07%
2021-12-31S$0.39 B60.2%
2020-12-31S$0.24 B0.8%
2019-12-31S$0.24 B92.15%
2018-12-31S$0.12 B24.02%
2017-12-31S$0.10 B68.97%
2016-12-31S$60.36 M36.22%
2015-12-31S$44.31 M-74.93%
2014-12-31S$0.17 B76.1%
2013-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merit Medical
MMSI
S$1.41 B 157.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
S$0.33 B-38.19%๐Ÿ‡บ๐Ÿ‡ธ USA